Feyh J
Klinik und Poliklinik für Hals-, Nasen-, Ohrenkranke, Klinikum Grosshadern, Universität München, Germany.
J Photochem Photobiol B. 1996 Nov;36(2):175-7. doi: 10.1016/s1011-1344(96)07366-6.
A clinical study using photodynamic therapy (PDT) for the treatment of head and neck cancer was conducted between 1988 and 1994. 83 patients with Tis-2 tumors of the face, oropharynx and larynx were included into the study protocol. The study was designed in accordance with the GCP-guidelines as a prospective controlled protocol. At 48 h after an intravenous injection of 2 mg kgbw-1 Photosan-3 the laser illumination (630 nm) of the tumor and tumor-surrounding tissue was performed at 100 mW cm-2 and 100 J cm-2. A control biopsy from the former tumor area was taken 2 months after PDT to evaluate the histological response of the treated tumors. 51 out of 57 patients with basal cell carcinoma, 6 out of 7 patients with squamaous cell carcinoma of the skin, 6 out of 7 patients with oropharynx carcinoma and 11 out of 12 patients with larynx carcinoma showed a complete histologically confirmed response to the tumor following a single course of PDT over a follow up time of 13-71 months.
1988年至1994年间开展了一项使用光动力疗法(PDT)治疗头颈癌的临床研究。83例面部、口咽和喉部Tis-2期肿瘤患者被纳入研究方案。该研究按照GCP指南设计为前瞻性对照方案。静脉注射2mg/kg bw-1的光神霉素3(Photosan-3)后48小时,以100mW/cm²和100J/cm²的功率对肿瘤及肿瘤周围组织进行激光照射(630nm)。光动力疗法后2个月,从前肿瘤区域取对照活检样本,以评估治疗后肿瘤的组织学反应。在13至71个月的随访期内,57例基底细胞癌患者中的51例、7例皮肤鳞状细胞癌患者中的6例、7例口咽癌患者中的6例以及12例喉癌患者中的11例,经组织学确认对肿瘤有完全反应。